Showing results (161-170 of 170) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Brain Communications|October 10, 2024
Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegenerationRozanna Meijboom, Peter Foley, Niall J J MacDougall, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trialRuggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, et al.BMJ Open|June 29, 2022
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosisPatrick K A Kearns, Sarah J Martin, Jessie Chang, et al.Journal of the American Academy of Dermatology|August 3, 2019
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension studyMette Deleuran, Diamant Thaçi, Lisa A Beck, et al.Brain : a Journal of Neurology|April 21, 2021
Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathyElba Pascual-Goñi, Janev Fehmi, Cinta Lleixà, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2026
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping studyEmma Vyvey, Rani Soenen, Hazel H Oon, et al.Journal of the American Academy of Dermatology|November 8, 2011
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of expertsDedee F Murrell, Benjamin S Daniel, Pascal Joly, et al.Journal of the American Academy of Dermatology|December 3, 2014
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of expertsDedee F Murrell, Branka Marinovic, Frederic Caux, et al.BMJ Open|February 1, 2023
Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensusCharis Wong, Jenna M Gregory, Jing Liao, et al.The World Allergy Organization Journal|August 30, 2024
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptionsFiona James, Michelle S Goh, Sara Vogrin, et al.Pageof 17